Theatre improves the emotional symptoms of people with Parkinson's
Peer-Reviewed Publication
Updates every hour. Last Updated: 22-Dec-2025 05:11 ET (22-Dec-2025 10:11 GMT/UTC)
A research team at the Universitat Oberta de Catalunya (UOC), working with the Hospital Sant Pau in Barcelona, has shown that theatre can improve the emotional well-being of people with Parkinson's disease. The study, "Efficacy of a theatre-based intervention in patients with Parkinson's disease" (2025), which has been published in open access in the journal Arts & Health, has provided the first evaluation of the combined effects of active and passive participation in theatre activities on these patients' emotional and cognitive health and quality of life. The researchers were also supported by the Teatre Lliure.
A new AI model is much better than doctors at identifying patients likely to experience cardiac arrest.
The linchpin is the system’s ability to analyze long-underused heart imaging, alongside a full spectrum of medical records, to reveal previously hidden information about a patient’s heart health.
Gene therapy can improve hearing in children and adults with congenital deafness or severe hearing impairment, a new study involving researchers at Karolinska Institutet reports. Hearing improved in all ten patients, and the treatment was well-tolerated. The study was conducted in collaboration with hospitals and universities in China and is published in the journal Nature Medicine.
Researchers at ETH have used nuclear magnetic resonance to find out what other atoms are bound to the platinum atoms in a single-atom catalyst and where they are spatially located.
The precise knowledge of the atomic environments can help produce single-atom catalysts that are more uniform, and thus more effective.
This also enables very efficient and resource-saving reaction accelerators for sustainable chemicals.
Amplification-free, highly sensitive, and specific nucleic acid detection is crucial for health monitoring and diagnosis. The type III CRISPR-Cas10 system, which provides viral immunity through CRISPR-associated protein effectors, enables a new amplification-free nucleic acid diagnostic tool. In this study, we develop a CRISPR-graphene field-effect transistors (GFETs) biosensor by combining the type III CRISPR-Cas10 system with GFETs for direct nucleic acid detection. This biosensor exploits the target RNA-activated continuous ssDNA cleavage activity of the dCsm3 CRISPR-Cas10 effector and the high charge density of a hairpin DNA reporter on the GFET channel to achieve label-free, amplification-free, highly sensitive, and specific RNA detection. The CRISPR-GFET biosensor exhibits excellent performance in detecting medium-length RNAs and miRNAs, with detection limits at the aM level and a broad linear range of 10-15 to 10-11 M for RNAs and 10-15 to 10-9 M for miRNAs. It shows high sensitivity in throat swabs and serum samples, distinguishing between healthy individuals (N = 5) and breast cancer patients (N = 6) without the need for extraction, purification, or amplification. This platform mitigates risks associated with nucleic acid amplification and cross-contamination, making it a versatile and scalable diagnostic tool for molecular diagnostics in human health.